[187 Pages Report] The Allergy Diagnostics Market size was estimated at USD 5.92 billion in 2023 and expected to reach USD 6.49 billion in 2024, at a CAGR 10.35% to reach USD 11.80 billion by 2030.
An allergy diagnosis is a test performed by a qualified specialist to determine if the patient’s body is allergic to known chemicals. Allergy diagnostics tests estimate the number of typical antibodies or proteins in the body that are associated with allergies. Rising cases of allergic diseases such as atopic dermatitis, hives, and allergic conjunctivitis are expected to elevate the need for accurate allergy diagnosis. The incidence of multiple allergic diseases among the population expands the preference for early detection and diagnosis of the allergen, creating a requirement for effective diagnostic tests or systems. However, limited awareness about allergic diseases and high costs of diagnostic tests, and the limited availability of trained professionals can impede the market development over the forecast period. Furthermore, the emerging emphasis on research activities to develop new allergy diagnostic tests or kits based on AI and ML by companies is creating an opportunity for market development.
Regional Insights
Europe has a significant landscape in the allergy diagnostics market due to a developed pharmaceutical industry and increasing demand for therapeutics. The growing geriatric population and rising incidences of allergic conditions also contribute to the region’s growth. The market is expected to grow in the Americas in coming years owing to the high incidence of respiratory allergic disorders, rising awareness levels about allergy diagnostics, and the adoption of in vitro blood tests. The FDA has guided the food industry, consumers, and other stakeholders on the best ways to assess and manage allergen hazards in food. The Center for Biologics Evaluation and Research (CBER) regulates several allergenic products that contributed to market growth in North America. Asia-Pacific is expected to be the fastest-growing regional market due to rapidly improving healthcare infrastructure, unmet clinical needs, and demand for minimally invasive diagnostic tools. Saudi Arabia has a growing landscape in the allergy diagnostics market, as the UAE manufactures and exports major parts of instruments and consumables required for allergy diagnostics.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Allergy Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Allergy Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Allergy Diagnostics Market, highlighting leading vendors and their innovative profiles. These include ALK-Abell? A/S, Allergy Therapeutics PLC, Astra Biotech GmbH, Bausch & Lomb Incorporated, Biom?rieux SA, Danaher Corporation, Dr. Fooke-Achterrath Laboratorien GmbH, DST Diagnostische Systeme & Technologien GmbH, Erba Group, Eurofins Scientific, EUROIMMUN Medizinische Labordiagnostika AG, HAL Allergy B.V., Hitachi, Ltd., HOB Biotech Group Corp., Ltd., HollisterStier by Jubilant Life Sciences Limited, HYCOR Biomedical, Lincoln Diagnostics, Inc., Minaris Medical America, Inc., Neogen Corporation, Omega Diagnostics Group PLC, Parkway Pantai Ltd., R-Biopharm AG, Romer Labs Division Holding GmbH by Royal DSM, ROXALL Medizin GmbH, Siemens AG, Stallergenes Greer International AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Allergy Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Type
- Drug Allergen
- Food Allergen
- Inhaled Allergen
- Product Type
- Assay Kits
- Consumables
- Instruments
- Immunoassay Analyzers
- Luminometers
- Test
- In-Vitro Tests
- In-Vivo Tests
- End User
- Academic Research Institutes
- Diagnostic Laboratories
- Hospital-Based Laboratories
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Allergy Diagnostics Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Allergy Diagnostics Market?
- What are the technology trends and regulatory frameworks in the Allergy Diagnostics Market?
- What is the market share of the leading vendors in the Allergy Diagnostics Market?
- Which modes and strategic moves are suitable for entering the Allergy Diagnostics Market?
US $
Euro €
GBP £